Replies to post #4036 on Aytu BioScience Inc. (AYTU)

[suha]

The Company expects to pursue U.S. regulatory clearance and expects to consult with the U.S. Food and Drug Administration about qualifying the test under FDA's Emergency Use Authorization

[altruism]

Because it traded 180 million dollars today and it's hard to hold a hundred eighty million dollar buys back